Sanjay Kaul

Cedars-Sinai Medical Center — United States

Medicine · Health Sciences

73h-index31.7kcitations307works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antiplatelet Therapy and Cardiovascular Diseases(44), Coronary Interventions and Diagnostics(42), Cardiac Imaging and Diagnostics(39), Lipoproteins and Cardiovascular Health(38), Health Systems, Economic Evaluations, Quality of Life(36)

Publications304 total

T-TEER for Severe Tricuspid Regurgitation in the TRILUMINATE Pivotal Trial
JAMA Cardiology·2025
Methodological Appraisal of Ongoing Trial of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Younger Patients: From Incentives to Guideline-Informing Evidence
European Journal of Cardio-Thoracic Surgery·2025
Making Government-Funded Health Insurance an Effective Strategy for Universal Health Coverage
2025
Reappraisal of Evidentiary Support for Transcatheter Aortic Valve Implantation for Low-Risk Aortic Stenosis
Journal of the American College of Cardiology·2025· 3 cited
From the Hazards of Death to the Hazards of Indication Creep for TAVR
Journal of the American College of Cardiology·2025· 1 cited
Evidentiary Landscape of Heart Failure Therapies, Regulatory Decisions, and Translation Into Guidelines
Journal of the American College of Cardiology·2025· 4 cited
Time-to-event analysis of the long-term outcome in trials comparing transcatheter and surgical aortic valve implantation: A meta-analysis.
International Journal of Cardiology·2025Open Access
Reevaluating Beta-Blocker Recommendations Post-Myocardial Infarction
Journal of the American College of Cardiology·2025· 1 cited
The 2025 Guideline Update Endorses Ticagrelor Monotherapy After ≥1 Month of DAPT Post-PCI in Patients With ACS
Journal of the American College of Cardiology·2025· 2 cited
Unblinded trials of transcatheter interventions with subjective endpoints: what are the implications?
EuroIntervention·2025· 1 cited
Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis
Journal of the American College of Cardiology·2025· 2 cited
Are ORBITA trials practice-changing?
Progress in Cardiovascular Diseases·2025· 1 cited
Unentangling Heart Failure From Kidney Outcomes With Finerenone
Journal of the American College of Cardiology·2025· 1 cited
TIME-TO-EVENT ANALYSIS OF MORTALITY AND STROKE IN TRIALS COMPARING TRANS-CATHETER AND SURGICAL AORTIC VALVE IMPLANTATION WITH DIFFERENT RISK PROFILES.
Journal of Cardiovascular Medicine·2024
Choice of End Points in Heart Failure Trials—Cause-Specific or All-Cause or Both?
JAMA Network Open·2024· 3 citedOpen Access
Bayesian Analytical Methods in Cardiovascular Clinical Trials: Why, When, and How
Canadian Journal of Cardiology·2024· 18 citedOpen Access
Should the 3-year follow-up of FAME-3 trial guide clinical practice? A critical appraisal
Journal of Thoracic and Cardiovascular Surgery·2024
Conflicts of interest in clinical practice: lessons learned from cardiovascular medicine.
PubMed·2024· 3 citedOpen Access
Stopping Trials Early for Benefit
Journal of the American College of Cardiology·2024
More questions than answers after NOTION-2
European Heart Journal·2024· 1 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

Prediman K. Shah(14), Timothy J. Gardner(8), Debabrata Mukherjee(8), Bojan Cercek(8), Deepak L. Bhatt(7), David R. Holmes(7), Jane A. Linderbaum(7), George Diamond(7), Michael J. Mack(6), A. Pieter Kappetein(6), John D. Fisher(6), Robert A. Harrington(6), Victor A. Ferrari(6), Karen P. Alexander(5), John Calhoon(5), Milind Y. Desai(5), Catherine M Otto(5), Carlos E. Ruiz(5), Deborah J. Wesley(5), Howard H. Weitz(5)